{
  "schema_version": "0.4",
  "ir_kind": "core",
  "metadata": {
    "title": "Protocol",
    "source": {
      "type": "paper_pdf",
      "id": "s41596-023-00880-1.pdf"
    }
  },
  "resources": {
    "materials": [
      {
        "id": "m1",
        "name": "APEL medium"
      },
      {
        "id": "m2",
        "name": "TeSR-E6 medium"
      },
      {
        "id": "m3",
        "name": "CDBLY2"
      },
      {
        "id": "m4",
        "name": "FGF9"
      },
      {
        "id": "m5",
        "name": "WNT activator"
      },
      {
        "id": "m6",
        "name": "Transwell membrane"
      }
    ],
    "containers": [
      {
        "id": "c1",
        "type": "culture_plate"
      },
      {
        "id": "c2",
        "type": "transwell_insert"
      }
    ],
    "equipment": [
      {
        "id": "e1",
        "type": "incubator"
      }
    ],
    "samples": [
      {
        "id": "samp1",
        "name": "human pluripotent stem cells (hPSCs)"
      }
    ],
    "data": []
  },
  "protocol": {
    "steps": [
      {
        "id": "s1",
        "op": "annotate",
        "params": {
          "note": "Protocol overview: directed differentiation of hPSCs to PT-enhanced kidney organoids using APEL or TeSR-E6 medium, prolonged WNT induction, FGF9, and CDBLY2."
        },
        "outputs": [],
        "inputs": []
      },
      {
        "id": "s2",
        "op": "annotate",
        "params": {
          "note": "Monolayer cells aggregated on day 13, transferred to Transwell membrane for airâ€“medium interface culture, followed by 14 days in TesR-E6 basal medium with FGF9 exposure."
        },
        "outputs": [],
        "inputs": []
      }
    ],
    "start_step_id": "s1",
    "edges": [
      {
        "from": "s1",
        "to": "s2"
      }
    ],
    "detail_level": 0
  }
}